Q32 Bio
QTTB
106 hedge funds and large institutions have $343M invested in Q32 Bio in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 33 reducing their positions, and 17 closing their positions.
3% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 33
0% more funds holding
Funds holding: 106 → 106 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 17
0.48% less ownership
Funds ownership: 4.2% → 3.73% (-0.48%)
6% less capital invested
Capital invested by funds: $364M → $343M (-$21.5M)
76% less call options, than puts
Call options by funds: $659K | Put options by funds: $2.75M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$10.2M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$6.83M |
| 3 |
JP Morgan Chase
New York
|
+$5.29M |
| 4 |
PAM
Premier Asset Management
Chicago,
Illinois
|
+$828K |
| 5 |
EAM
Erste Asset Management
Vienna,
Austria
|
+$827K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$26.9M |
| 2 |
5VM
5AM Venture Management
San Francisco,
California
|
-$10.7M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$9M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.18M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$5.04M |
QTTB Hedge Fund Activity: Q4 2020 in Review
106 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q4 2020, worth a combined $343M — down 5.9% from $364M a quarter earlier.
Fund positioning in QTTB was balanced in Q4 2020: 17 funds opened new positions, 17 closed out, 34 added to existing stakes and 33 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $10.2M. The largest seller was RTW Investments, exiting entirely with an estimated $26.9M sold.
- 106 institutional investors held Q32 Bio (QTTB) as of Q4 2020, unchanged from Q3 2020.
- Funds reported $343M of Q32 Bio stock for Q4 2020, down 5.9% quarter-over-quarter.
- 17 funds opened new Q32 Bio positions in Q4 2020 and 17 closed out, a net change of 0 holders.
- The largest Q32 Bio buyer in Q4 2020 was Citadel Advisors, an estimated $10.2M added.
- The largest Q32 Bio seller in Q4 2020 was RTW Investments, an estimated $26.9M sold.
Based on aggregated 13F filings for Q4 2020.